FDA Approved: XERMELO — Supplemental Application (Lexicon Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for XERMELO (telotristat ethyl) from Lexicon Pharmaceuticals, Inc. This action updates the regulatory status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• XERMELO (telotristat ethyl)

Snippet

SUPPL AP for XERMELO (TELOTRISTAT ETHYL)